Watch CBS News

Moderna Says Its COVID Vaccine More Than 90% Effective 6 Months After Second Dose

CAMBRIDGE (CBS) - Moderna said new data shows its COVID-19 vaccine continues to provide strong protection.

The Cambridge company said the latest information from its phase 3 study of the vaccine, which started last year, shows it is more than 90-percent effective against the virus six months after the second dose.

Moderna is also working on boosters targeting variants of coronavirus.

"The new preclinical data on our variant-specific vaccine candidates give us confidence that we can proactively address emerging variants. Moderna will make as many updates to our COVID-19 vaccine as necessary until the pandemic is under control," CEO Stéphane Bancel said in a statement Tuesday,

They've also enrolled 3,000 participants in a study of the vaccine in kids ages 12-to-17. A study of children ages 6 months to 11 years is still looking for candidates.

Moderna's two-shot vaccine is currently approved for emergency use in the U.S. for anyone age 18 and older.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.